Launch · 28 February 2026LemniscaDigital twin platform for fermentation
Lemnisca builds digital twin for bioprocess scale-up
By Abha Lohia · Editor ·
pre-seed
- Lemnisca is building a digital twin platform that simulates fermentation to help biotech manufacturers scale bioprocesses from lab to industrial volumes
- The startup, founded by Shilpa Nargund and Pushkar Pendse, has built in-house wet lab capabilities to improve model accuracy and plans to take on one or two…
- India's bio-economy has surged 16-fold to $165.7 billion in the last decade, and the global bioprocessing industry is growing at 11.39% CAGR to $228.73…
What happened
- Lemnisca is building a digital twin platform for fermentation to help biotech manufacturers scale bioprocesses from lab to industrial volumes.
- The platform uses a hybrid model that simulates living cell behaviour and physical conditions to predict bioprocess outcomes at scale.
- The startup has built in-house wet lab capabilities to generate data for improving the accuracy of its digital twin model.
- Lemnisca is agnostic to industry or product type; any molecule naturally made can be produced with microbes.
- The company plans to take on one or two microbial processes in 2025, creating a specific product like a chemical or protein.
- Its next milestone is to prove the technology is innovative and fit for a manufacturing setting.
- Future growth could be horizontal (more processes across customers or molecule types) or vertical (multiple steps in manufacturing for one molecule).
- The startup plans to cater equally to Indian and international customers.
Why it matters
- India's bio-economy has surged 16-fold to $165.7 billion in the last 10 years.
- The global bioprocessing industry is growing at 11.39% CAGR to $228.73 billion by 2033.
- The Union Budget FY27 allocated ₹10,000 crore for the Biopharma Shakti scheme over five years to boost biologics and biosimilars.
- India is the third-largest biotech market in Asia-Pacific and top 12 globally, but its share in the global biotech market is below 3%.
- Lemnisca's digital twin for bioprocessing is unique in the Indian context.
The business
- Lemnisca builds a digital twin platform for fermentation processes.
- The platform uses a hybrid model simulating living cell behaviour and physical conditions.
- It predicts bioprocess outcomes at scale, helping manufacturers move from lab to industrial volumes.
- The startup has in-house wet lab capabilities to generate data for model accuracy.
- Lemnisca is agnostic to industry or product type; any molecule naturally made can be produced with microbes.
The founders
SN
Shilpa Nargund
founder- Holds a doctorate in chemical engineering.
- Has 15 years of experience as a bioprocess industry veteran.
- Previously worked at Insilico Biotechnology Singapore.
PP
Pushkar Pendse
co-founder- Has expertise in modelling chemical processes.
In numbers
$228.73 BnGlobal bioprocessing industry size by 2033
11.39%Global bioprocessing industry CAGR
$165.7 BnIndia's bio-economy
₹10,000 croreUnion Budget allocation for Biopharma Shakti scheme · FY27
What happens next
- Take on one or two microbial processes in 2025, creating a specific product like a chemical or protein.
- Prove the technology is innovative and fit for a manufacturing setting.
- Future growth could be horizontal (more processes across customers or molecule types) or vertical (multiple steps in manufacturing for one molecule).
- Cater equally to Indian and international customers.
Up against
Differential Bio (Germany)Invert Bio (US)Insilico (Germany)
Words to know
- digital twin
- A virtual replica of a physical process or system that uses real-time data and simulation to predict outcomes and optimize performance.
- fermentation
- A biological process where microorganisms like bacteria or yeast convert organic substances into products such as chemicals, proteins, or medicines.
- bioprocessing
- The use of living cells or their components to produce desired products, such as drugs, enzymes, or biofuels, on a commercial scale.
- wet lab
- A laboratory where experiments involve handling liquids, chemicals, and biological materials, as opposed to computer-only simulations.
Other articles talking about it
Terms in this story
- Startup: A startup is a young company built to find a new way of doing something and to grow fast, usually by serving many customers at little extra cost. India also has a legal definition for scheme benefits: under ten years old, turnover under ₹200 crore, and working on innovation or a scalable model.
- Funding stage: Startups raise money in steps called funding stages: pre-seed, seed, Series A, B, C and later, ending in a listing or a sale. Each step is larger and asks for more proof. In India, Series A rounds run from a few million dollars to about $15 million, as of November 2026.
- Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
Read next
FundingHenfruit raises $15 million in first outside roundHenfruit sells packaged, graded and lab-tested eggs, and has run on its own money since 2014NewsFarmwiseAI maps 40 million Tamil Nadu land parcelsFarmwiseAI is a Chennai startup, founded around six years ago, that combines artificial intelligence with mapping data to solve farm and land problemsResultsEggoz revenue climbs 39% as losses widenEggoz, a Gurugram brand run by Nupa Technologies, sources eggs from local poultry farmers and supplies retailers within a day
All startup news on 28 February 2026 →
Is this Lemnisca? Get your “Featured on StopDown” badge →